Association study of TLR4 polymorphisms with severe community-acquired pneumonia susceptibility and outcome

Chinese Journal of Emergency Medicine

Volumn 18, Issue 9, 2009, Pages 956-959

  Song, Zhen Ju ^a   Tong, Chao Yang ^a   Sun, Zhan ^a   Yao, Chen Ling ^a   Shoo, Mian ^a   Huang, Pei Zhi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Prognosis; Severe community acquired pneumonia; Single nucleotide polymorphism; Susceptibili ty; Tlr4

Indexed keywords

EID: 70349694464     PISSN: 16710282     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1671-0282.2009.09.014     Document Type: Article

References (14)

1. Song JH, Won OS, Kang CI, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens[j]. Int J Antimicrob Agents, 2008, 31(2): 107-114.
2. Ylipalosaari P, Ala-Kokko TI, Laurila J, et al. Community- and hospital-acquired infections necessitating ICU admission: spectrum, co-morbidities and outcome[j]. J Infect, 2006, 53(2):85-92.
3. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong[j]. N Engl J Med, 2003, 348(20): 1986-1994. (Pubitemid 36569987)
4. Brookes AJ. The essence of SNPs[j].Gene, 1999, 234(2): 177-186.
5. Hawn TR, Verbon A, Janer M, et al. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease [j]. PNAS, 2005, 102 (7):2487-2489.
6. Niederman MS, Mandril LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia, diagnosis, assessment of severity, antimicrobial therapy, and prevention[J]. Am J Respir Crit Care Med, 2001, 163 (7) : 1730-1754.
7. Barrett JC, Fry B, Mailer J, et al. Haploview: analysis and visualization of LD and haplotype maps[j]. Bioinformatics, 2005, 21(2): 263-265.
8. 2008, 17(11): 1191-1194.
9. Leulier F, Lemaitre B. Toll-like receptors-taking an evolutionary ap-proach[j].Nat Genet Reviews, 2008, 9(3): 165-178.
10. Matsuzawa A, Saegusa K, Noguchi T, et al. ROS-dependent activation of the TRAF6-ASKl-p38 pathway is selectively required for TLR4-me-diated innate immunity[j]. Nat Immunol, 2005, 6(6):587-592.
11. Agnese DM, Calvano JE, Hahm SJ, et al. Human Toll-Like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infectionst [J]. J Infect Dis, 2002, 186(10): 1522-1525.
12. Marsik C, Jilma B, Joukhadar C, et al. The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia[J]. Clin Chem, 2005, 51(11): 2178-2180.
13. Ferwerda B, Mccalla MB, Alonsod S, et al. TLR4 polymorphism, infectious diseases, and evolutionary pressure during migration of modem humans [J].PNAS, 2007, 104(42): 16645-16650.
14. The international Hapmap consortium.The international Hapmap project [J]. Nature, 2003, 4(6):779-789.